Piperacillin-tazobactam compared with cefoxitin as antimicrobial prophylaxis for pancreatoduodenectomy. A randomized clinical trial.
D’Angelica MI, Ellis RJ, Liu JB, Brajcich BC, Gonen M, Thompson VM et al.
JAMA 2023; 329: 1579-1588.
The trial was stopped after interim analysis of 778 procedures. The combination of piperacillin and tazobactam reduced the risk of surgical site infection at 30 days: 19.8 versus 32.8 per cent, P<0.001. It also reduced the rate of relevant postoperative pancreatic fistula: 12.7 versus 19 per cent, P=0.03.
Comment: Promising new combination for open pancreatic surgery.
19 July 2023
Read paperAcademy
Part of the charitable activity of the Society, BJS Academy is an online educational resource for current and future surgeons.
The Academy is comprised of five distinct sections: Continuing surgical education, Young BJS, Cutting edge, Scientific surgery and Surgical news. Although the majority of this is open access, additional content is available to BJS subscribers and strategic partners.
